Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls

Joshua D. Woolley, Brandon Chuang, C. Fussell, Stefan Scherer, Bruno Biagianti, Daniel Fulford, Daniel H. Mathalon, Sophia VinogradovPsychological 2017 · DOI

Abstract

These results demonstrate that oxytocin administration can increase facial expressivity in response to emotional stimuli and suggest that oxytocin may have the potential to serve as a treatment for blunted facial affect in schizophrenia.
BibTeX
@inproceedings{woolley2017intranasal,
  author = {Joshua D. Woolley and Brandon Chuang and C. Fussell and Stefan Scherer and Bruno Biagianti and Daniel Fulford and Daniel H. Mathalon and Sophia Vinogradov},
  title = {{Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls}},
  booktitle = {Psychological},
  year = {2017},
  doi = {10.1017/s0033291716003433},
}

Loading related content...

Figure